Reaction from StemCells, Inc. to Two Papers in Stem Cell Reports on the Efficacy of Human NSCs in Mouse Models of Alzheimer's Disease and Spinal Cord Injury.
机构信息
Newark, CA 94560, USA;
出版信息
Stem Cell Reports. 2017 Feb 14;8(2):194-195. doi: 10.1016/j.stemcr.2017.02.001.
Abstract
摘要
相似文献
1
Reaction from StemCells, Inc. to Two Papers in Stem Cell Reports on the Efficacy of Human NSCs in Mouse Models of Alzheimer's Disease and Spinal Cord Injury.干细胞公司对发表于《干细胞报告》上的两篇关于人类神经干细胞在阿尔茨海默病和脊髓损伤小鼠模型中疗效的论文的反应。
Stem Cell Reports. 2017 Feb 14;8(2):194-195. doi: 10.1016/j.stemcr.2017.02.001.
2
Stem-cell treatments for spinal-cord injury may be worth the risk.脊髓损伤的干细胞治疗可能值得冒险一试。
Nature. 2009 Apr 30;458(7242):1101. doi: 10.1038/4581101a.
3
Long-term fate of allogeneic neural stem cells following transplantation into injured spinal cord.同种异体神经干细胞移植入损伤脊髓后的长期命运。
Stem Cell Rev Rep. 2010 Mar;6(1):121-36. doi: 10.1007/s12015-009-9104-y.
4
HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease.HuCNS-SC人神经干细胞在阿尔茨海默病转基因模型中无法分化、形成异位簇且无认知益处。
Stem Cell Reports. 2017 Feb 14;8(2):235-248. doi: 10.1016/j.stemcr.2016.12.019.
5
Selective killing of spinal cord neural stem cells impairs locomotor recovery in a mouse model of spinal cord injury.脊髓神经干细胞的选择性杀伤可损害脊髓损伤小鼠模型的运动功能恢复。
J Neuroinflammation. 2018 Feb 23;15(1):58. doi: 10.1186/s12974-018-1085-9.
6
7
[TRANSPLANTATION OF NEURAL STEM CELLS INDUCED BY ALL-TRANS- RETINOIC ACID COMBINED WITH GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR AND CHONDROITINASE ABC FOR REPAIRING SPINAL CORD INJURY OF RATS].全反式维甲酸联合胶质细胞源性神经营养因子及软骨素酶ABC诱导神经干细胞移植修复大鼠脊髓损伤
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2015 Aug;29(8):1009-15.
8
The Application of Neural Stem/Progenitor Cells for Regenerative Therapy of Spinal Cord Injury.神经干细胞/祖细胞在脊髓损伤再生治疗中的应用。
Curr Stem Cell Res Ther. 2019;14(6):495-503. doi: 10.2174/1574888X14666190329095638.
9
What is the potential of oligodendrocyte progenitor cells to successfully treat human spinal cord injury?少突胶质前体细胞治疗人类脊髓损伤的潜力如何？
BMC Neurol. 2011 Sep 23;11:113. doi: 10.1186/1471-2377-11-113.
10
Hypoxia-preconditioned adipose tissue-derived mesenchymal stem cell increase the survival and gene expression of engineered neural stem cells in a spinal cord injury model.缺氧预处理脂肪组织来源的间充质干细胞增加了脊髓损伤模型中工程化神经干细胞的存活和基因表达。
Neurosci Lett. 2010 Mar 26;472(3):215-9. doi: 10.1016/j.neulet.2010.02.008. Epub 2010 Feb 11.
引用本文的文献
1
Regenerative Therapies for Spinal Cord Injury.脊髓损伤的再生治疗。
Tissue Eng Part B Rev. 2019 Dec;25(6):471-491. doi: 10.1089/ten.TEB.2019.0182. Epub 2019 Oct 23.
2
Cellular therapy for traumatic neurological injury.创伤性神经损伤的细胞治疗。
Pediatr Res. 2018 Jan;83(1-2):325-332. doi: 10.1038/pr.2017.253. Epub 2017 Nov 1.
本文引用的文献
1
Preclinical Efficacy Failure of Human CNS-Derived Stem Cells for Use in the Pathway Study of Cervical Spinal Cord Injury.用于颈脊髓损伤通路研究的人中枢神经系统来源干细胞的临床前疗效失败
Stem Cell Reports. 2017 Feb 14;8(2):249-263. doi: 10.1016/j.stemcr.2016.12.018.
2
HuCNS-SC Human NSCs Fail to Differentiate, Form Ectopic Clusters, and Provide No Cognitive Benefits in a Transgenic Model of Alzheimer's Disease.HuCNS-SC人神经干细胞在阿尔茨海默病转基因模型中无法分化、形成异位簇且无认知益处。
Stem Cell Reports. 2017 Feb 14;8(2):235-248. doi: 10.1016/j.stemcr.2016.12.019.
Zotero 插件